The Varieties of Religious Experience: 263. Penguin Classics, 1983 (first edition 1902).
National Collaborating Centre for Mental Health.
Alcohol-Use Disorders. Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence
. NICE Clinical Guideline 115. British Psychological Society & Royal College of Psychiatrists, 2011.
Miller, WR, Wilbourne, PL.
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction
2002; 97: 265–77.
Home Office. The Government's Alcohol Strategy. Cm 8336. TSO (The Stationery Office), 2012.
Hickman, M, Carnwath, Z, Madden, P, Farrell, M, Rooney, C, Ashcroft, R, et al.
Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London. J Urban Health
2003; 80: 274–87.
Connock, M, Juarez-Garcia, A, Jowett, S, Frew, E, Liu, Z, Taylor, RJ, et al.
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess
2007; 11: 1–171.
World Health Organization Regional Office for Europe. The European Tobacco Control Report 2007. WHO, 2007.
Reus, VI, Smith, BJ.
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines. Int J Clin Pract
2008; 62: 1753–68.
Psychedelic Psychiatry: LSD from Clinic to Campus. Johns Hopkins University Press, 2008.
Dr Leary's Concord Prison experiment: a 34-year follow-up study. Psychoactive Drugs
1998; 30: 419–26.
Hendricks, PS, Clark, CB, Johnson, MW, Fontaine, KR, Cropsey, KL.
Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. J Psychopharmacol
2014; 28: 62–6.
MacLean, KA, Johnson, MW, Griffiths, RR.
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol
2011; 25: 1453–61.
The use of hallucinogens in the treatment of addiction. Addiction Res
1996; 4: 177–89.
Bogenschutz, MP, Pommy, JM.
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. Drug Test Anal
2012; 4: 543–55.
Krupitsky, EM, Grinenko, AY.
Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. J Psychoactive Drugs
1997; 29: 165–83.
Shaping the renaissance of psychedelic research. Lancet
2012; 380: 200–1.